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a  b  s  t  r  a  c  t
Chordoma  is  a rare  neoplasm  of bone  that  develops  from  the  remnants  of  the  primitive  notochord.  We
present  a 78-year-old  woman  with  metastatic  chordoma  to the  left  ventricle.  She  had  been  diagnosed
with  sacral  chordoma  5  years  earlier,  and  chordoma  gradually  spread  to  numerous  muscles,  the  ankle
joint of  the  left  leg,  bilateral  lungs,  and  the  brain,  despite  repeated  surgical  excisions  and  carbon  heavy-ion
radiotherapy.  Positron  emission  tomography/computed  tomography  showed  an  abnormal  accumulation
in the  heart,  with  features  similar  to the  other  metastatic  lesions.  Transthoracic  echocardiography  could
not provide  a clear  view  of  the  heart,  but  multidetector  computed  tomography  revealed  that  a  giant
abnormal  mass  was  attached  to the  apical  inferior  segment  of  the  left ventricle.  The patient  stated  that
she did  not  want  to undergo  surgical  resection  for the  cardiac  mass.  The  chordoma  has  been  slowly
increasing  in  size,  but  she  has  remained  asymptomatic  without  cardiovascular  events  for  more  than  a
year since  the  diagnosis  of cardiac  metastasis.
<Learning  objective:  Multidetector  computed  tomography  provided  information  not  only  about  the
structure morphology  of  the  left ventricular  mass,  but  also  about  the pathological  features  using  the
attenuation  values  of  computed  tomography,  enabling  us  to make  a diagnosis  of  a  metastatic  lesion  to
ral  ch
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Chordoma is an extremely rare neoplasm of bone that devel-
ps from the remnants of the primitive notochord [1,2]. Regardless
f the pathology, chordoma is thought to be clinically malignant
ecause it shows continuous growth, and no effective therapy has
et been established [1,2]. We  present a woman with sacral chor-
oma who was found to have metastasis to the left ventricle, which
as clearly demonstrated on multidetector computed tomography.
ase report
A 78-year-old woman was referred to the Department of Cardi-
logy in our hospital for a cardiac examination, although she did not
ave any chest symptoms. She had suffered from lumbago for a long
ime and had been diagnosed with sacral chordoma 5 years ear-
ier. The chordoma had gradually spread to numerous muscles, the
nkle joint of the left leg, and bilateral lungs, despite repeated sur-
ical excisions and carbon heavy-ion radiotherapy. Chordoma had
etastasized to the brain 2 years earlier, and image-guided radio-
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surgery using the CyberKnife System (Accuray Inc., Sunnyvale, CA,
USA) was performed with little effectiveness. A few weeks earlier,
18F-ﬂuorodeoxyglucose positron emission tomography/computed
tomography showed an abnormal accumulation in the heart, with
features like those seen in her other metastatic lesions, such as the
right anterior serratus muscle (Fig. 1). Medications included oxy-
codone, pregabalin, meloxicam, mecobalamin, and famotidine. She
did not smoke or drink alcohol.
On examination, the patient was  alert. Her blood pressure was
120/75 mmHg, pulse was  80 beats per minute and regular, and
oxygen saturation was 98% while she was breathing ambient air.
The jugular veins were not distended; a grade 2/6 systolic ejec-
tion murmur was  audible at the apex, without the third or fourth
sounds; respiratory sound was  clear throughout both lung ﬁelds;
and pretibial edema was not present.
Electrocardiography showed sinus rhythm and terminal T wave
inversions in the V3 and V4 leads. Chest X-ray showed several small
nodules in both lung ﬁelds that were consistent with metastatic
lesions of the lung from chordoma. The blood level of N-terminal
pro-brain natriuretic peptide was elevated to 131 pg/ml (reference
range, ≤55 pg/ml), but the remainder of the blood test results were
within normal limits with no evidence of diabetes mellitus (fas-
ting blood glucose, 82 mg/dl; hemoglobin A1c, 5.5%). Transthoracic
echocardiography showed a left ventricular ejection fraction of 65%
vier Ltd. All rights reserved.
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Fig. 1. A coronal view of 18F-ﬂuorodeoxyglucose positron emission tomogra-
phy/computed tomography shows a high accumulation in the apex of the left
ventricle (arrow). An abnormal accumulation in the right anterior serratus muscle
(arrow head) and probably physiological uptake in the stomach are also noted.
Fig. 2. A volume rendering image after removal of the right ventricle (A), and a vertical
ventricle on multidetector computed tomography with contrast media.logy Cases 7 (2013) e21–e23
with mild mitral regurgitation; an abnormal mass in the apex of the
left ventricle was suggestive but the details were difﬁcult to assess
due to the poor image quality. Multidetector computed tomogra-
phy (LightSpeed VCT, GE Healthcare, Milwaukee, WI,  USA) revealed
that an abnormal mass was  attached to the apical inferior segment
of the left ventricle; the giant mass with little enhancement after
the administration of contrast media was 32 mm × 17 mm × 11 mm
in size (Fig. 2). Attenuation values in the abnormal mass of
the left ventricle were low (ranging 10–50 Hounsﬁeld units), as
compared with those of the normal left ventricular myocardium
(ranging 90–130 Hounsﬁeld units), features consistent with values
of metastatic muscle which was surgically excised and proven to
be chordoma pathologically. The detailed morphology of the left
ventricular mass was  clearly demonstrated on dynamic computed
tomography (Supplementary Movie 1). A mild stenosis in the mid
portion of the left descending artery was also shown on coronary
computed tomography.
She was ﬁnally diagnosed to have a metastatic lesion to the
left ventricle from sacral chordoma. She has refused any invasive
procedures to the heart. The metastatic lesion in the left ventricle
has been slowly increasing in size but she has remained asymp-
tomatic without cardiovascular events for more than a year after
the diagnosis of cardiac metastasis was made.Discussion
We experienced a case of a 78-year-old woman with chor-
doma who was incidentally diagnosed as having an abnormal mass
 view (B), a horizontal view (C), and a short-axis view (D) of the end-diastolic left
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n the left ventricle on18F-ﬂuorodeoxyglucose positron emission
omography/computed tomography. The left ventricular mass was
onsidered to be metastatic chordoma on the basis of analyz-
ng attenuation values on multidetector computed tomography,
lthough no pathologic specimens were obtained from the patient.
urthermore, multidetector computed tomography was useful in
ssessing the detailed morphology of the cardiac lesion.
The incidence of chordoma is less than 0.1 per 100,000 person-
ears [2,3]. The site of the original chordoma was reported to be the
pine in 50–60% of patients, the skull base region in 25–35%, and
he vertebrae in about 15% [4].  In 25 consecutive patients consisting
f 18 men  and 7 women with a mean age of 62 years (ranging
rom 40 to 77 years) [5],  the initial symptoms were pain and/or
eurological impairment, and the 5-year and 10-year survival rates
ere 77% and 60%, respectively. Surgical resection with adequate
argins seems to be the only curative treatment for chordoma,
nd radiotherapy with protons or chemotherapy with molecular
argeting agents is optional [1,2,5].  The present patient underwent
epeated surgical excisions with carbon heavy-ion radiotherapy,
ut the chordoma has been progressively growing.
The metastatic incidence of chordoma has been considered rel-
tively low (approximately 30%); distant metastases can develop
n lung, bone, soft tissue, liver, lymph nodes, or skin [4–6]. A few
ases of metastatic chordoma to the right ventricle have been
eported [7–9], however few data are available regarding cardiac
etastasis to the left ventricle, as in our case. In 1970, Yarom
nd Horn [10] reported a case of sacrococcygeal chordoma with
even small cardiac metastases located in the right atrium, the
nterior wall of the right ventricle, the posterior papillary mus-
le of the tricuspid valve, and the lateral wall and apex of the left
entricle, which were conﬁrmed on autopsy. In the present case,
8F-ﬂuorodeoxyglucose positron emission tomography and mul-
idetector computed tomography enabled us to make a diagnosis
f metastatic chordoma to the left ventricle during life. The car-
iac mass has increased in size, indicating that careful follow-up is
andatory, because the metastatic mass in the left ventricle could
[logy Cases 7 (2013) e21–e23 e23
lead to adverse events, e.g. ventricular arrhythmia, distal embolism,
or low cardiac output.
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Appendix A. Supplementary data
Supplementary data associated with this article can be
found, in the online version, at http://dx.doi.org/10.1016/
j.jccase.2012.09.008.
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